Candriam SCA’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.1M | Sell |
211,167
-413,271
| -66% | -$37.7M | 0.09% | 207 |
|
|
2026
Q1 | $64.1M | Sell |
624,438
-394,377
| -39% | -$44.5M | 0.33% | 63 |
|
|
2025
Q4 | $128M | Sell |
1,018,815
-153,545
| -13% | -$19.6M | 0.64% | 28 |
|
|
2025
Q3 | $157M | Buy |
1,172,360
+125,477
| +12% | +$16.5M | 0.82% | 17 |
|
|
2025
Q2 | $142M | Buy |
1,046,883
+407,813
| +64% | +$53.8M | 0.82% | 20 |
|
|
2025
Q1 | $84.8M | Buy |
639,070
+45,315
| +8% | +$5.77M | 0.53% | 35 |
|
|
2024
Q4 | $67.2M | Buy |
593,755
+265,750
| +81% | +$30.7M | 0.39% | 56 |
|
|
2024
Q3 | $37.4M | Sell |
328,005
-31,671
| -9% | -$3.47M | 0.21% | 106 |
|
|
2024
Q2 | $37.4M | Buy |
359,676
+56,167
| +19% | +$5.96M | 0.23% | 96 |
|
|
2024
Q1 | $34.5M | Sell |
303,509
-322,925
| -52% | -$37M | 0.22% | 109 |
|
|
2023
Q4 | $69M | Sell |
626,434
-119,098
| -16% | -$11.9M | 0.48% | 45 |
|
|
2023
Q3 | $72.2M | Sell |
745,532
-104,370
| -12% | -$11M | 0.51% | 40 |
|
|
2023
Q2 | $92.7M | Sell |
849,902
-46,599
| -5% | -$4.97M | 0.67% | 29 |
|
|
2023
Q1 | $83.6M | Sell |
896,501
-148,229
| -14% | -$15.7M | 0.58% | 33 |
|
|
2022
Q4 | $115M | Sell |
1,044,730
-92,209
| -8% | -$9.55M | 0.77% | 21 |
|
|
2022
Q3 | $110M | Buy |
1,136,939
+293,977
| +35% | +$31.3M | 0.78% | 18 |
|
|
2022
Q2 | $91.6M | Buy |
842,962
+30,372
| +4% | +$3.45M | 0.75% | 24 |
|
|
2022
Q1 | $96.2M | Buy |
812,590
+26,892
| +3% | +$3.33M | 0.65% | 30 |
|
|
2021
Q4 | $111M | Buy |
785,698
+204,459
| +35% | +$26.2M | 0.71% | 30 |
|
|
2021
Q3 | $68.7M | Sell |
581,239
-79,305
| -12% | -$9.74M | 0.47% | 49 |
|
|
2021
Q2 | $76.6M | Buy |
660,544
+192,623
| +41% | +$22.5M | 0.52% | 43 |
|
|
2021
Q1 | $49.2M | Buy |
467,921
+4
| +0% | +$474 | 0.41% | 54 |
|
|
2020
Q4 | $51.2M | Sell |
467,917
-132,853
| -22% | -$14.4M | 0.41% | 54 |
|
|
2020
Q3 | $65.4M | Buy |
600,770
+124,711
| +26% | +$12.7M | 0.61% | 29 |
|
|
2020
Q2 | $43.5M | Sell |
476,059
-180,303
| -27% | -$16.3M | 0.46% | 45 |
|
|
2020
Q1 | $55.7M | Buy |
656,362
+16
| +0% | +$1.33K | 0.62% | 29 |
|
|
2019
Q4 | $57M | Sell |
656,346
-40,718
| -6% | -$3.41M | 0.61% | 29 |
|
|
2019
Q3 | $58.3M | Sell |
697,064
-18,753
| -3% | -$1.59M | 0.77% | 22 |
|
|
2019
Q2 | $59.9M | Buy |
715,817
+150,066
| +27% | +$11.8M | 0.75% | 22 |
|
|
2019
Q1 | $45.2M | Sell |
565,751
-46,893
| -8% | -$3.49M | 0.58% | 32 |
|
|
2018
Q4 | $44.3M | Buy |
612,644
+28,026
| +5% | +$1.97M | 0.68% | 27 |
|
|
2018
Q3 | $42.9M | Sell |
584,618
-42,892
| -7% | -$2.82M | 0.57% | 32 |
|
|
2018
Q2 | $38.3M | Sell |
627,510
-1,529
| -0.2% | -$92.7K | 0.61% | 27 |
|
|
2018
Q1 | $37.7M | Buy |
629,039
+183,537
| +41% | +$11.1M | 0.64% | 23 |
|
|
2017
Q4 | $25.4M | Sell |
445,502
-14,816
| -3% | -$821K | 0.44% | 52 |
|
|
2017
Q3 | $24.6M | Buy |
460,318
+201,696
| +78% | +$10.1M | 0.43% | 52 |
|
|
2017
Q2 | $12.6M | Sell |
258,622
-366,442
| -59% | -$16.6M | 0.24% | 113 |
|
|
2017
Q1 | $27.8M | Buy |
625,064
+196,395
| +46% | +$8.49M | 0.54% | 31 |
|
|
2016
Q4 | $16.5M | Sell |
428,669
-2,182
| -0.5% | -$86.5K | 0.38% | 64 |
|
|
2016
Q3 | $18.2M | Sell |
430,851
-270,408
| -39% | -$11.6M | 0.44% | 57 |
|
|
2016
Q2 | $27.6M | Buy |
701,259
+564,323
| +412% | +$22.5M | 0.72% | 29 |
|
|
2016
Q1 | $5.7M | Buy |
+136,936
| New | +$5.43M | 0.14% | 171 |
|
|
2015
Q4 | – | Sell |
-267,363
| Closed | -$10.8M | – | 556 |
|
|
2015
Q3 | $10.8M | Sell |
267,363
-102,202
| -28% | -$4.82M | 0.26% | 114 |
|
|
2015
Q2 | $18.1M | Buy |
369,565
+9,457
| +3% | +$454K | 0.38% | 66 |
|
|
2015
Q1 | $16.7M | Buy |
360,108
+74,655
| +26% | +$3.43M | 0.34% | 73 |
|
|
2014
Q4 | $12.8M | Buy |
+285,453
| New | +$12.4M | 0.27% | 115 |
|
Other funds holding ABT
Candriam SCA's ABT Position: Q2 2026 in Review
Candriam SCA reduced its Abbott (ABT) stake by 66% in Q2 2026, selling an estimated $37.7M and leaving 211,167 shares worth $19.1M. The position accounts for 0.09% of the portfolio, ranked #207.
Candriam SCA first reported a position in ABT in Q4 2014 and has held it in 46 quarters since. The position peaked at $157M in Q3 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Candriam SCA held 211,167 shares of Abbott worth $19.1M as of Q2 2026.
- Candriam SCA sold 413,271 Abbott shares in Q2 2026, an estimated $37.7M.
- Abbott made up 0.09% of Candriam SCA's portfolio in Q2 2026, its #207 holding.
- Candriam SCA first reported a position in Abbott in Q4 2014 and has held it in 46 quarters since.
- Candriam SCA's Abbott position peaked at $157M in Q3 2025.
- 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.